Medicine

L. V. Bruwaene, R. Green, J. Joshi, J. Cloete

2020.10.1Current Allergy & Clinical Immunology

DOI: 10.10520/ejc-caci-v33-n3-a6

tlooto Summary

The case of a South African child, infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presenting with reactive urticaria and thrombocytosis is presented, further broadening the clinical spectrum of COVID-19 in children.

Abstract

Coronavirus SARS-CoV-2 has made a significant impact around the world through COVID-19 and its related complications Individuals with comorbid conditions and the elderly have been at risk of significant inflammatory complications, including the cytokine release syndrome (CRS) and acute respiratory distress syndrome (ARDS) Children, on the other hand, have been less affected and have had less severe disease However, reports from Europe and North America have described clusters of children and adolescents with paediatric multisystem inflammatory syndrome Both adults and children have also exhibited a number of unusual disease manifestations We present the case of a South African child, infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presenting with reactive urticaria and thrombocytosis, further broadening the clinical spectrum of COVID-19 in children

Citation format

BRUWAENE, L. V., et al. Reactive urticaria and severe thrombocytosis in a child with SARS-CoV-2 infection. Current Allergy & Clinical Immunology, 2020, 33: 154–156.